
Oct 23, 2026 · 33 min
Listen from 16:12
Listen at 16:12
Moderna’s cancer data sparks a market frenzy and bigger questions
Why Moderna Tanked, MSG Employees Duped By Their Boss, The Mansion Section | Diet TBPN
The episode connects speculative trading, fragile medical interpretation, workplace manipulation, data security, and military biotechnology.
- 1Promising early cancer data can trigger dramatic market moves before the underlying evidence supports sweeping conclusions.
- 2A simulated Knicks championship-ring offer exposed the uneasy line between phishing awareness and employee trust.
- 3Medical breaches, AI parenting tools, and engineered military animals reveal how technology reshapes risk in ordinary life and defense.
Don't miss
The hosts dissect Madison Square Garden’s fake Knicks championship-ring offer and debate whether a phishing test crossed into employee humiliation.
The brief
Moderna’s cancer-therapy data sends the stock into a volatile frenzy, while John Coogan and Jordi Hays question claims that early results amount to a cure.
The hosts revisit influencer Togi’s options gamble, separating a lucky trade from the confident thesis he later attached to it.
A promised Knicks championship ring becomes a simulated phishing test for Madison Square Garden employees, raising questions about whether security training can become demoralizing.
The episode widens from Quest Diagnostics’ exposed patient data to an AI parenting assistant, asking what happens when sensitive systems become ordinary infrastructure.
The closing detour surveys an Alaskan family compound and Warhound’s genetically engineered military-animal ideas, ending with technology that sounds closer to science fiction than policy.
What was said on this episode
32 statements · 13 positive · 8 negative · 5 mixed · 6 neutral
The body naturally fights off some cancerous activity.
“there's always some level of cancer in your body that your body's naturally fighting off.”
Listen at 1:57
Personalized mRNA vaccines can train immunity to attack a patient’s cancer cells.
“scientists sequence a patient. tumor, identify mutations unique to their specific cancer, and then manufacture an mRNA vaccine that teaches the immune system to recognize and attack those cancer cells.”
Listen at 3:28
Moderna’s vaccine-Keytruda combination may prevent recurrence and treat multiple cancers.
“the hope is that the combination can prevent cancer from returning after surgery and eventually work against many different types of cancer.”
Listen at 3:47
Phase-two results showed a 49% relative reduction in recurrence or death.
“a 49% reduction in relative risk of cancer recurrence or death compared to Keytruda alone.”
Listen at 3:59
Moderna’s phase-three cancer trial succeeded but underperformed investor expectations.
“the phase three did succeed, but the results weren't as spectacular as investors had hoped”
Listen at 5:48
Moderna’s phase-three trial succeeded but underwhelmed investor expectations.
“the phase three did succeed, but the results weren't as spectacular as investors had hoped.”
Listen at 5:48
Phase-three results showed a 42% relative risk reduction, below phase two’s 49%.
“Instead of the 49% that I mentioned before, it was only 42%”
Listen at 5:53
Moderna’s phase-three trial showed a 42% relative-risk reduction, below the earlier 49%.
“Instead of the 49% that I mentioned before, it was only 42%”
Listen at 5:53
Moderna’s treatment begins showing effectiveness only after six months.
“the phase three trial showed that Moderna's treatment is really only starts to be effective after six months”
Listen at 6:16
Moderna’s treatment begins showing effectiveness only after six months.
“Moderna's treatment is really only starts to be effective after six months.”
Listen at 6:17
Moderna’s treatment offers limited benefit for aggressive, fast-growing cancers.
“if you have a really aggressive, fast growing cancer, it doesn't really help all that much.”
Listen at 6:24
Moderna’s treatment provides limited benefit for aggressive, fast-growing cancers.
“if you have a really aggressive, fast growing cancer, it doesn't really help all that much”
Listen at 6:24
Moderna’s stock rose 25% over two weeks after Togi bought calls.
“Over the next two weeks, the stock went up 25%.”
Listen at 9:59
Moderna shares fell 26% shortly after trial results leaked.
“Shortly after, the results were leaked and the stock crashed by 26%.”
Listen at 11:16
Moderna’s stock fell 26% shortly after the trial results leaked.
“Shortly after, the results were leaked and the stock crashed by 26%.”
Listen at 11:16
Using Grok for parenting advice is an especially contrarian choice.
“going to Grok for parenting advice is probably the most.”
Listen at 15:37
Using Grok for parenting advice is an especially contrarian choice.
“going to Grok for parenting advice is probably the most”
Listen at 15:37
Joe Lonsdale’s contrarian success makes Grok parenting advice more tempting.
“it makes me way more tempted to start going to grok for parenting.”
Listen at 16:12
Grok may become a major parenting product.
“Might be looking at the next great parenting product.”
Listen at 16:16
Grok may have an opportunity to reposition around parenting.
“Maybe there's an opportunity here to reposition Grok around.”
Listen at 16:20
Scott Wu’s mental-math ability is a learned skill.
“I think this is a learned skill.”
Listen at 19:05
Madison Square Garden sent a fake championship-ring email as a phishing test.
“But the email was a fake out. A phishing test Madison Square Garden sent to see if those employees would click.”
Listen at 21:01
A phishing test is acceptable if careful inspection reveals the email is fraudulent.
“if there is actually something about it, that if you inspect the email thoroughly enough, you can tell it's a phishing email.”
Listen at 22:15
Cybercriminals could exploit championship-ring phishing emails to breach team-related systems.
“It might even happen, right? Like, hey, when a team wins a championship, send a phishing email about rings to everybody involved, and let's try to break into their systems that way.”
Listen at 23:21
Severe cybersecurity threats justify using almost any phishing-test scenario.
“Given the level of cybersecurity threats, almost nothing is off the table for phishing.”
Listen at 24:23
CEOs should use impersonating actors to conduct in-person phishing tests.
“I think that CEOs should be hiring actors to put on full Hollywood makeup to go into the office as them and try and phish employees in person.”
Listen at 24:29
Quest Diagnostics will probably face settlement or class-action costs.
“they'll probably have to pay out some sort of settlement or class action.”
Listen at 26:07
Humans will be unable to understand the AI financial system controlling their lives.
“We will not be able to understand the AI financial system that will control our lives in”
Listen at 27:20
The 147-acre Alaska property with a helipad is listed for $12.5 million.
“147 acres with a helipad. Guess how much it's going for? They're giving it away. Just $12.5 million.”
Listen at 28:02
The Alaska compound is listed for $12.5 million.
“Just $12.5 million.”
Listen at 28:08
Richard Stryken’s Alaska property spans 147 acres and overlooks glaciers and mountains.
“His 147-acre property has views of the glaciers, mountain ranges, and northern lights.”
Listen at 28:45
Warhound is developing genetically engineered dogs for military and law-enforcement use.
“Ben Lamb and Palmer have Warhound, a company coming out of stealth to genetically engineer dogs for military and law enforcement.”
Listen at 30:23
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Weekly email
State of the Pod, every Monday
The week's most-discussed names and stories from podcasts, with the moments behind them. Free, five minutes, unsubscribe in one click.